Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

BACKGROUND: The messenger RNA (mRNA)–based vaccines BNT162b2 and mRNA-1273 are more than 90% effective against coronavirus disease 2019 (Covid-19). However, their comparative effectiveness for a range of outcomes across diverse populations is unknown. METHODS: We emulated a target trial using the el...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickerman, Barbra A., Gerlovin, Hanna, Madenci, Arin L., Kurgansky, Katherine E., Ferolito, Brian R., Figueroa Muñiz, Michael J., Gagnon, David R., Gaziano, J. Michael, Cho, Kelly, Casas, Juan P., Hernán, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693691/
https://www.ncbi.nlm.nih.gov/pubmed/34942066
http://dx.doi.org/10.1056/NEJMoa2115463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693691/
https://www.ncbi.nlm.nih.gov/pubmed/34942066
http://dx.doi.org/10.1056/NEJMoa2115463

Ejemplares similares